Tevogen Bio Holdings Inc. - Common Stock (TVGN)
7.7500
+0.4400 (6.02%)
NASDAQ · Last Trade: Mar 9th, 4:24 PM EDT
U.S. stock futures lower, with Dow futures down over 1%. BETA Technologies (NYSE: BETA) fell in pre-market trading after reporting fourth-quarter results. Other stocks declining in pre-market trading include Zymeworks (NASDAQ: ZYME), Olema Pharmaceuticals (NASDAQ: OLMA), Brand Engagement Network (NASDAQ: BNAI), Aura Biosciences (NASDAQ: AURA), Tevogen Bio Holdings (NASDAQ: TVGN), ArcelorMittal SA (NYSE: MT), Invivyd (NASDAQ: IVVD), ORIC Pharmaceuticals (NASDAQ: ORIC), York Space Systems (NYSE: YSS), and Heartland Express (NASDAQ: HTLD).
Via Benzinga · March 9, 2026
The announcement comes on the heels of the company announcing that it has entered into a letter of intent to evaluate a deal with another pharmaceutical company called Apozel Pharmaceuticals.
Via Stocktwits · March 6, 2026
If the deal goes through, it could provide Tevogen with an established generics platform, the company said.
Via Stocktwits · March 5, 2026
Discover the top movers in Wednesday's pre-market session.chartmill.com
Via Chartmill · March 4, 2026
In a stunning blow to the burgeoning field of allogeneic cell therapy, Atara Biotherapeutics (Nasdaq: ATRA) saw its market valuation evaporate this week following a second Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for its lead candidate, tabelecleucel (Ebvallo). The regulatory setback, which the
Via MarketMinute · January 14, 2026
Let's have a look at what is happening on the US markets on Monday. Below you can find the stocks with an unusual volume in today's session.
Via Chartmill · August 11, 2025
Via Benzinga · April 29, 2025
Via Benzinga · April 29, 2025
The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today.
Via Chartmill · April 28, 2025
Tevogen Bio Holdings shares are ripping higher in Monday's after-hours session after the company reaffirmed its oncology pipeline revenue forecast.
Via Benzinga · April 28, 2025
Via Benzinga · April 28, 2025

D Boral Capital initiates Buy on Tevogen Bio citing its scalable T-cell therapies and upcoming clinical readouts, with a $10 price target.
Via Benzinga · March 4, 2025

Via Benzinga · March 4, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · January 27, 2025

As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · January 27, 2025

Tevogen Bio Holdings Inc (NASDAQ:TVGN) shares are trading higher Monday after the company announced an expanded AI collaboration with Microsoft Corp (NASDAQ:MSFT).
Via Benzinga · January 27, 2025

Via Benzinga · January 27, 2025

U.S. stock futures dropped sharply on Monday after China released DeepSeek, an AI model that demonstrates high performance at a lower cost.
Via Benzinga · January 27, 2025

Via Benzinga · January 27, 2025

Via Benzinga · November 20, 2024

Via Benzinga · November 20, 2024

Tevogen Bio Holdings Inc. (NASDAQ: TVGN) shares are trading higher Monday, potentially driven by momentum from a late-Friday announcement regarding operational updates. Here's what you need to know.
Via Benzinga · November 11, 2024

Via Benzinga · November 4, 2024

A look at the most-searched tickers on Benzinga Pro for the month of October. Donald Trump and biotech stocks joined the top 10.
Via Benzinga · November 4, 2024

Via Benzinga · October 28, 2024
